Delivery Order SPE2DB25D7067-SPE2DB25FSVSL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Latuda 20 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a firm fixed price ceiling value of $46,374.90 and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $29,470.00 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's...
- This is a $2,526.46 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 40mg Latuda tablets. The contract, which has no set-aside designation, has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support the healthcare needs of military treatment facilities, veterans' hospitals, and other federal healthcare providers. This award is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Latuda 20 mg tablets in a 30-count package, with a total ceiling value of $1,846.96 and an ultimate completion date of December 31, 2024. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 20 mg tablets, a medication used to treat certain mental health conditions. The Delivery Order has a ceiling value of $3,458.41 and an ultimate completion date of May 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,052.65, is for the delivery of LATUDA 120 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
- This is a $8,663.90 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of LATUDA 40 MG TABLET 30S, a pharmaceutical product. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products to support military...
- This firm fixed price delivery order, valued at $2,135.40, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LATUDA 20 MG TABLET 30S. The order has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,572.93 firm-fixed-price contract is for the delivery of Latuda 80 mg tablets, a specialty medication used to treat mental health conditions. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVSLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables the supply of a wide range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally. This delivery order for Latuda, an atypical antipsychotic medication, reflects the company's ongoing role in fulfilling pharmaceutical needs across the federal medical supply chain without set-aside designation, demonstrating its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 8/28/25 |